Search

Your search keyword '"Weiss DR"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Weiss DR" Remove constraint Author: "Weiss DR"
83 results on '"Weiss DR"'

Search Results

1. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor

4. Isolation and characterization of a phospholipase A2 from an inflammatory exudate

7. Europe gets serious about [CO.sub.2] trading. (Emissions Trading)

17. Antibodies attenuate the capacity of dendritic cells to stimulate HIV-specific cytotoxic T lymphocytes

18. Balanced Permeability Index: A Multiparameter Index for Improved In Vitro Permeability.

19. Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies.

20. Trends in Neosubstrate Degradation by Cereblon-Based Molecular Glues and the Development of Novel Multiparameter Optimization Scores.

21. On Ternary Complex Stability in Protein Degradation: In Silico Molecular Glue Binding Affinity Calculations.

22. Lead Exposure Among Workers at a Shipyard-Wisconsin, 2015 to 2016.

23. Selectivity Challenges in Docking Screens for GPCR Targets and Antitargets.

24. Structure-based discovery of selective positive allosteric modulators of antagonists for the M 2 muscarinic acetylcholine receptor.

25. Temporal and Provincial Variation in Ambulance Use Among Patients Who Present to Acute Care Hospitals With ST-Elevation Myocardial Infarction.

26. GPCR-Bench: A Benchmarking Set and Practitioners' Guide for G Protein-Coupled Receptor Docking.

27. Decoding the Role of Water Dynamics in Ligand-Protein Unbinding: CRF1R as a Test Case.

28. Correlation of the hypotonic shock response and extent of shape change with the new ThromboLUX ™.

29. Structures of mGluRs shed light on the challenges of drug development of allosteric modulators.

30. 'New' direct oral anticoagulants in the perioperative setting.

31. The influence of four different anticoagulants on dynamic light scattering of platelets.

32. Millisecond dynamics of RNA polymerase II translocation at atomic resolution.

33. von Willebrand factor, clotting factors, and clotting inhibitors in apheresis platelet concentrates.

34. SAMPL4 & DOCK3.7: lessons for automated docking procedures.

35. The influence of pre-analytical conditions on platelet-derived microparticles.

36. Morphing methods to visualize coarse-grained protein dynamics.

37. Von Willebrand factor multimer structure is neither acutely nor chronically affected by plateletpheresis.

38. Muscarinic receptors as model targets and antitargets for structure-based ligand discovery.

39. Focus on cardiac pericytes.

40. Conformation guides molecular efficacy in docking screens of activated β-2 adrenergic G protein coupled receptor.

41. A detailed examination of platelet function inhibition by nitric oxide in platelet-rich plasma and whole blood.

42. Microparticle detection in platelet products by three different methods.

44. The structure of the von Willebrand factor is not altered in patients with colorectal carcinoma.

45. Physician counseling of older adults about physical activity: the importance of context.

46. Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4.

47. Regulation of coronary venular barrier function by blood borne inflammatory mediators and pharmacological tools: insights from novel microvascular wall models.

48. Is coagulation factor VIII a useful marker for colorectal carcinoma?

49. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.

50. Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: the second most frequent myocardial cell type in vitro.

Catalog

Books, media, physical & digital resources